DEUTETRABENAZINE FOR THE TREATMENT OF DYSKINESIA IN CEREBRAL PALSY

The disclosure is directed to methods of treating dyskinesia in cerebral palsy in human patients using deutetrabenazine and its active metabolites. La divulgación se refiere a métodos para tratar la discinesia en la parálisis cerebral en pacientes humanos usando deutetrabenazina y sus metabolitos ac...

Full description

Saved in:
Bibliographic Details
Main Authors GORDON Mark Forrest, SAVOLA Juha- Matti, SCHNEIDER Frank
Format Patent
LanguageEnglish
Spanish
Published 10.12.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure is directed to methods of treating dyskinesia in cerebral palsy in human patients using deutetrabenazine and its active metabolites. La divulgación se refiere a métodos para tratar la discinesia en la parálisis cerebral en pacientes humanos usando deutetrabenazina y sus metabolitos activos.
Bibliography:Application Number: MX20210007063